International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Organizing Committee

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

• Jan-Willem Alffenaar, PharmD, PhD - The University of Sydney School of Pharmacy, Australia
• Deron Burton, MD, JD, MPH - CDC/OID/NCHHSTP, USA
• Dakshina Chilukuri, PhD - FDA, USA
• Veronique Dartois, PhD - Rutgers, The State University of New Jersey, USA
• Paolo Denti , PhD - University of Cape Town, South Africa
• Kelly Dooley, MD, PhD - Johns Hopkins University, USA
• Tawanda Gumbo, MD - Southwestern Medical Center, USA
• Richard Hafner, MD - NIH, USA
• Scott Heysell , MD, MPH - University of Virginia, USA
• Anneke Hesseling, MD - South Africa
• Russell Kempker , MD, MSc - Emory University School of Medicine, USA
• Steven Kern, PhD - Bill & Melinda Gates Foundation, USA
• Christian Lienhardt, MD, PhD - WHO, Stop TB Department, France
• Khisi Mdluli, PhD, Bill & Melinda Gates Medical Research Institute, USA
• Rovina Ruslami , MD, PhD - Padjadjaran University, Indonesia
• Ulrika Simonsson, PharmD, PhD - Uppsala University, Sweden
• Susan Swindells, MBBS - University of Nebraska Medical Center, USA
• Bob Wallis, PhD - The Aurum Institute, South Africa